ZIMMER BIOMET HOLDINGS INC
For the period ended Jun 30, 2024. Filed Aug 7, 2024.
View on SEC.govAbout this filing
A company's report for each of its first three quarters. The financial statements are not audited. It shows how the business has moved since the last annual report, and what management says changed.
Jun 30, 2024 · Filed Aug 7, 2024
Extracted filing text, with the paragraph anchors used by the comparison.
See the whole filing, with its images and exhibitsContents
Unregistered Sales of Equity Securities and Use of Proceeds
Item 2. Unregistered Sales of Equity Securities and Use of Proceeds
Issuer Purchases of Equity Securities
The following table summarizes repurchases of common stock settled during the three-month period ended June 30, 2024:
| Period · Total Number of Shares Purchased · Average Price Paid per Share · Total Number of Shares Purchased as a Part of Publicly Announced Program(1) · Maximum Approximate Dollar Value of Shares that may yet bePurchased Under the Program(1) | |||||
|---|---|---|---|---|---|
| April 2024 | - | $ | - | - | $67,828,222 |
| May 2024 | - | - | - | 2,000,000,000 | |
| June 2024 | 888,000 | 107.43 | 888,000 | 1,904,602,369 | |
| Total | 888,000 | $107.43 | 888,000 | $1,904,602,369 | |
(1) In February 2016, our Board of Directors authorized a $1.0 billion share repurchase program effective March 1, 2016, which authorization expired on May 29, 2024. In May 2024, our Board of Directors authorized a $2.0 billion share repurchase program effective May 29, 2024, with no expiration date. Subsequent to June 30, 2024 through August 5, 2024, we repurchased an additional 1.9 million shares for $207.0 million, resulting in $1,697.6 million remaining authorized under the May 2024 program as of August 5, 2024.
The text of this filing, as the company filed it with the SEC, without its images or exhibits. This is not investment advice.